Glaxo (GSK) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

HIV sales rose 14% driven by strong demand and ... Juluca rose 10% while Dovato was up 27% in the quarter. Rukobia sales rose 46% in the quarter. Sales of new long-acting medicines, Cabenuva ...

Feb. 18, 2025 — Viruses, like those that cause COVID-19 or HIV, are formidable opponents once they invade our bodies. Antiviral treatments strive to block a virus or halt its replication.

Queer HIV activist opens up about Trump and Musk's USAID cuts Ruele Okeyo posts videos of himself on TikTok taking his HIV medication. He says it is to reduce the stigma around it. But after USAID ...